Stay updated with breaking news from Analyst vosser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bayer believes it is on course for possible approval following positive study data on the active substance elinzanetant for the treatment of certain menopausal symptoms. This non-hormonal treatment. ....
Bayer believes it is on course for a possible approval following positive study data on the active substance elinzanetant for the treatment of certain menopausal symptoms. This non-hormonal treatment. ....